Effects of a Community Pharmacist-Based Diabetes Patient-Management Program on Intermediate Clinical Outcome Measures

• DOI: 10.18553/jmcp.2002.8.1.48
• Publication Date: 2016-02-21T14:30:15Z
• Authors: David Nau
• Keywords: 03 medical and health sciences; 0302 clinical medicine; 3. Good health

OBJECTIVES: Evaluate a community pharmacist-based diabetes patient-management program by examining the pharmacists' impact on five intermediate outcomes: glycosolated hemoglobin (HbA1c), blood pressure, body mass index, lipid levels, and medication use in patients with diabetes. SETTING: A network of community pharmacies in West Virginia and southeastern Ohio. PATIENTS: The program was available to all patients with diabetes who attended the network pharmacies regardless of baseline glycemic control. Of the 47 patients initially enrolled, 32 stayed in the program for at least 6 months during the year-long study (median time in program was 9 months). INTERVENTION: Pharmacists provided a basic, standardized diabetes education program during three 1-hour sessions. This was accompanied by a clinical assessment and a report to the patient's primary care physician. The patients met with the pharmacist every 3 months for continued monitoring. After each visit, the patient's primary care physician was sent a repo...